|
Antibiotics have emerged as a major
therapeutic class in India with around Rs.3500 crore
sales.
Amongst
antibiotics, Cephalosporins are growing fast, and at
double pace than the market, because of their proven
efficacy against different types of bacteria and their
unparalleled safety.
Cephalosporins are ranked amongst the top
ten therapeutic classes in the world contributing to
almost seven billion us dollars.
Aurobindo is a dominant player in the
Cephalosporins and caters to all leading players in the
world. Today it offers world’s largest product portfolio
with 20 different Cephalosporins. Aurobindo aggressively
reverse engineered and made available first, second,
third and fourth generation sterile and non-sterile
Cephalosporins. The availability of these latest
generation Cephalosporins has helped the medical
profession to administer more effective medicines with
excellent safety profile, contributing to rapid
acceptance of this class in most parts of the world.
Aurobindo's research
efforts brought the best 3rd generation oral
Cephalosporins like Cefixime, Cefpodoxime proxetil
Ceftibuten that has ushered in a new era in the
Cephalosporin usage.
Similarly Aurobindo brought the best 3rd
generation injectable cephalosporins like Cefotaxime,
Ceftriaxone, Ceftazidime, Cefuroxime sodium,
Cefoperazone, Ceftiofur. These sophisticated products
with worldwide acceptance & global quality have brought
a great recognition to India.
|